| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Beth C. Seidenberg | Director | 2025-12-18 | 133,333 | $7.50 | $1,000.00kBuy |
| Westlake Biopartners Opportunity Fund I LP | 10% Owner | 2025-12-18 | 133,333 | $7.50 | $1,000.00kBuy |
| Karen Marie Walker | Chief Technology Officer | 2025-12-15 | 23,998 | $4.83 | $115.91kBuy |
| Karen Marie Walker | Chief Technology Officer | 2025-12-15 | 23,998 | $12.20 | $292.78kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vida Ventures LLC | 10.91% | 4,777,060 | $42.04M | Insider |
| Fred E. Cohen | 10.37% | 4,540,558 | $39.96M | Insider |
| Gordonmd Global Investments LP | 10.03% | 4,391,818 | $38.65M | Institution |
| Gilead Sciences Inc | 9.42% | 4,126,119 | $36.31M | Institution |
| Gilead Sciences Inc | 9.42% | 4,126,119 | $36.31M | Insider |
| Beth C. Seidenberg | 8.69% | 3,804,574 | $33.48M | Insider |
| Westlake Biopartners Opportunity Fund I LP | 8.65% | 3,787,940 | $33.33M | Insider |
| Northpond Ventures III GP LLC | 7.43% | 3,255,426 | $28.65M | Insider |
| Bain Capital Life Sciences Investors LLC | 7.22% | 3,163,868 | $27.84M | Insider |
| Bain Capital Life Sciences Investors LLC | 7.10% | 3,110,000 | $27.37M | Institution |